HER2 Support Group Forums - View Single Post - Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer pat

News · 03-15-2013, 04:22 AM

Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.

More...

03-15-2013, 04:22 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer pat Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland. More...